Notification
No new Notification messages
Zinka Logistics Solutions IPO is Open!
Apply for the Zinka Logistics Solutions IPO through UPI in just minutes.
Q2 FY'24-25 Results of Top Companies
Reliance, TCS, HDFC Bank & more: Explore key financial highlights from India's top quarterly results.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
NSE BSE
ngl fine chem limited stock

NGL FINE CHEM LIMITED Share Price

1800 11.50 (0.64%)
Nov 21 2024 03:29 PM Pharmaceuticals NSE: NGLFINE

NGL FINE CHEM LIMITED Share Price Update

As of the latest trading session, NGL FINE CHEM LIMITED share price is currently at 1800, which is up by 11.50 from its previous closing. Today, the stock has fluctuated between 1761.35 and 1815.25. Over the past year, NGL FINE CHEM LIMITED has achieved a return of -8.43 %. In the last month alone, the return has been -15.07 %. Read More...

NGL FINE CHEM LIMITED Performance

Day Range

Low1761.35 High1815.25
1796.55

52 Week Range

Low 1702.35 High 2823.90
1796.55

NGL FINE CHEM LIMITED Share Price

10277

524774

NGLFINE

img img img img
No Data Available

Open Price

1815.25

Prev. Close

1788.50

Volume (Shares)

2485.00

Total traded value

44.64

Upper Circuit

2146.20

Lower Circuit

1430.80

Note: The current prices & values are delayed, Login to your account for live updates.

NGL FINE CHEM LIMITED Fundamentals


(Standalone)

Market Cap (Cr) 1112.04
PE Ratio (TTM) 29.65
Book Value / Share 451.95
Beta 0.93
ROE 15.78%
EPS (TTM) 60.87
Dividend Yield 0.10%
Net Profit Qtr (Cr) 10.04

NGL FINE CHEM LIMITED Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars SEP 2024 (Values in Cr)
Revenue 91.41
Operating Expense 83.41
Net Profit 10.04
Net Profit Margin (%) 10.98
Earnings Per Share (EPS) 16.26
EBITDA 16.05
Effective Tax Rate (%) 25.24
Particulars JUN 2024 (Values in Cr)
Revenue 88.03
Operating Expense 84.30
Net Profit 7.83
Net Profit Margin (%) 8.89
Earnings Per Share (EPS) 12.67
EBITDA 12.58
Effective Tax Rate (%) 21.80
Particulars MAR 2024 (Values in Cr)
Revenue 95.61
Operating Expense 85.53
Net Profit 10.85
Net Profit Margin (%) 11.34
Earnings Per Share (EPS) 17.56
EBITDA 16.76
Effective Tax Rate (%) 23.80
Particulars DEC 2023 (Values in Cr)
Revenue 84.81
Operating Expense 76.21
Net Profit 8.90
Net Profit Margin (%) 10.49
Earnings Per Share (EPS) 14.40
EBITDA 15.15
Effective Tax Rate (%) 30.46
Particulars SEP 2023 (Values in Cr)
Revenue 79.44
Operating Expense 68.67
Net Profit 10.97
Net Profit Margin (%) 13.80
Earnings Per Share (EPS) 17.76
EBITDA 16.90
Effective Tax Rate (%) 24.44
Particulars MAR 2024 (Values in Cr)
Revenue 328.97
Operating Expense 294.16
Net Profit 38.52
Net Profit Margin (%) 11.70
Earnings Per Share (EPS) 62.35
EBITDA 60.20
Effective Tax Rate (%) 24.03
Particulars MAR 2023 (Values in Cr)
Revenue 275.05
Operating Expense 256.07
Net Profit 20.12
Net Profit Margin (%) 7.31
Earnings Per Share (EPS) 32.56
EBITDA 35.70
Effective Tax Rate (%) 24.36
Particulars MAR 2022 (Values in Cr)
Revenue 318.67
Operating Expense 262.33
Net Profit 52.25
Net Profit Margin (%) 16.39
Earnings Per Share (EPS) 84.57
EBITDA 78.20
Effective Tax Rate (%) 24.25
Particulars MAR 2021 (Values in Cr)
Revenue 255.21
Operating Expense 190.73
Net Profit 55.47
Net Profit Margin (%) 21.73
Earnings Per Share (EPS) 89.79
EBITDA 85.23
Effective Tax Rate (%) 27.01
Particulars MAR 2020 (Values in Cr)
Revenue 152.18
Operating Expense 141.16
Net Profit 10.60
Net Profit Margin (%) 6.96
Earnings Per Share (EPS) 17.16
EBITDA 23.87
Effective Tax Rate (%) 26.13
Particulars MAR 2024 (Values in Cr)
Book Value / Share 425.11
ROE % 17.03
ROCE % 20.16
Total Debt to Total Equity 0.14
EBITDA Margin 20.04
Particulars MAR 2023 (Values in Cr)
Book Value / Share 360.23
ROE % 9.63
ROCE % 11.83
Total Debt to Total Equity 0.15
EBITDA Margin 14.56
Particulars MAR 2022 (Values in Cr)
Book Value / Share 328.94
ROE % 27.90
ROCE % 33.46
Total Debt to Total Equity 0.13
EBITDA Margin 24.84
Particulars MAR 2021 (Values in Cr)
Book Value / Share 250.01
ROE % 44.76
ROCE % 52.66
Total Debt to Total Equity 0.18
EBITDA Margin 34.16
Particulars MAR 2020 (Values in Cr)
Book Value / Share 160.18
ROE % 10.13
ROCE % 13.54
Total Debt to Total Equity 0.29
EBITDA Margin 16.52
Particulars MAR 2024 (Values in Cr)
Book Value / Share 425.39
ROE % 15.78
ROCE % 18.73
Total Debt to Total Equity 0.14
EBITDA Margin 18.44
Particulars MAR 2023 (Values in Cr)
Book Value / Share 365.04
ROE % 9.31
ROCE % 11.37
Total Debt to Total Equity 0.14
EBITDA Margin 13.21
Particulars MAR 2022 (Values in Cr)
Book Value / Share 334.36
ROE % 28.87
ROCE % 34.27
Total Debt to Total Equity 0.13
EBITDA Margin 24.65
Particulars MAR 2021 (Values in Cr)
Book Value / Share 251.62
ROE % 43.22
ROCE % 51.07
Total Debt to Total Equity 0.17
EBITDA Margin 33.15
Particulars MAR 2020 (Values in Cr)
Book Value / Share 163.81
ROE % 12.51
ROCE % 15.21
Total Debt to Total Equity 0.29
EBITDA Margin 17.40
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 1.72
Total Assets 355.53
Total Liabilities 355.53
Total Equity 262.63
Share Outstanding 6178024
Price to Book Ratio 4.91
Return on Assets (%) 11.62
Return on Capital (%) 14
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 13.04
Total Assets 287.07
Total Liabilities 287.07
Total Equity 222.54
Share Outstanding 6178024
Price to Book Ratio 3.28
Return on Assets (%) 7.13
Return on Capital (%) 8.1
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.82
Total Assets 276.92
Total Liabilities 276.92
Total Equity 203.21
Share Outstanding 6178024
Price to Book Ratio 5.86
Return on Assets (%) 18.01
Return on Capital (%) 21.69
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 4.77
Total Assets 207.38
Total Liabilities 207.38
Total Equity 154.45
Share Outstanding 6178024
Price to Book Ratio 6.09
Return on Assets (%) 27.34
Return on Capital (%) 34.29
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 3.15
Total Assets 153.62
Total Liabilities 153.62
Total Equity 98.96
Share Outstanding 6178024
Price to Book Ratio 1.55
Return on Assets (%) 5.42
Return on Capital (%) 6.84
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 1.59
Total Assets 353.04
Total Liabilities 353.04
Total Equity 262.80
Share Outstanding 6178024
Price to Book Ratio 4.91
Return on Assets (%) 10.91
Return on Capital (%) 13.05
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 12.94
Total Assets 288.11
Total Liabilities 288.11
Total Equity 225.52
Share Outstanding 6178024
Price to Book Ratio 3.28
Return on Assets (%) 6.98
Return on Capital (%) 7.86
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.73
Total Assets 277.72
Total Liabilities 277.72
Total Equity 206.56
Share Outstanding 6178024
Price to Book Ratio 5.86
Return on Assets (%) 18.81
Return on Capital (%) 22.38
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 4.69
Total Assets 205.79
Total Liabilities 205.79
Total Equity 155.45
Share Outstanding 6178024
Price to Book Ratio 6.09
Return on Assets (%) 26.95
Return on Capital (%) 33.33
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 3.07
Total Assets 155.58
Total Liabilities 155.58
Total Equity 101.20
Share Outstanding 6178024
Price to Book Ratio 1.55
Return on Assets (%) 6.81
Return on Capital (%) 8.54
Particulars MAR 2024 (Values in Cr)
Net Income 54.41
Cash from Operations 33.56
Cash from Investing -26.81
Cash from Financing -1.08
Net change in Cash -7.43
Free Cash Flow 62.08
Particulars MAR 2023 (Values in Cr)
Net Income 27.36
Cash from Operations 42.15
Cash from Investing -27.02
Cash from Financing -1.08
Net change in Cash 7.18
Free Cash Flow 73.55
Particulars MAR 2022 (Values in Cr)
Net Income 66.59
Cash from Operations 30.52
Cash from Investing -14.20
Cash from Financing -1.08
Net change in Cash -1.45
Free Cash Flow 86.90
Particulars MAR 2021 (Values in Cr)
Net Income 77.58
Cash from Operations 48.22
Cash from Investing -24.56
Cash from Financing -1.08
Net change in Cash 1.70
Free Cash Flow 65.43
Particulars MAR 2020 (Values in Cr)
Net Income 12.09
Cash from Operations 24.20
Cash from Investing -19.55
Cash from Financing -1.30
Net change in Cash -0.39
Free Cash Flow 39.34
Particulars MAR 2024 (Values in Cr)
Net Income 50.70
Cash from Operations 23.32
Cash from Investing -17.49
Cash from Financing -1.08
Net change in Cash -7.43
Free Cash Flow 51.33
Particulars MAR 2023 (Values in Cr)
Net Income 26.59
Cash from Operations 38.36
Cash from Investing -23.61
Cash from Financing -1.08
Net change in Cash 7.18
Free Cash Flow 67.47
Particulars MAR 2022 (Values in Cr)
Net Income 68.97
Cash from Operations 29.41
Cash from Investing -13.00
Cash from Financing -1.08
Net change in Cash -1.39
Free Cash Flow 44.26
Particulars MAR 2021 (Values in Cr)
Net Income 75.99
Cash from Operations 47.10
Cash from Investing -23.78
Cash from Financing -1.08
Net change in Cash 1.70
Free Cash Flow 52.22
Particulars MAR 2020 (Values in Cr)
Net Income 14.35
Cash from Operations 23.37
Cash from Investing -18.78
Cash from Financing -1.30
Net change in Cash -0.46
Free Cash Flow 30.66
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 55.85 32.10 3.04 428.00 37.54 / 77.70
BLISS GVS PHARMA LTD 120.75 15.11 1.25 1271.52 92.25 / 148.95
CIPLA LTD 1471.35 25.74 4.18 118825.56 1165.10 / 1702.00
FERMENTA BIOTECH LIMITED 331.20 115.00 3.35 974.75 145.00 / 354.60
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 55.85 48.57 9.49 428.00 37.54 / 77.70
AMRUTAJAN HEALTH LTD 720.90 43.85 6.99 2084.17 556.05 / 861.40
ASTRAZENECA PHARMA IND LT 6497.50 126.19 23.91 16243.75 4050.15 / 8139.85
BLISS GVS PHARMA LTD 120.75 15.72 1.24 1271.52 92.25 / 148.95

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 1834.80
  • 26 Days 1961.50
  • 10 Days 1894.40
  • 50 Days 2016.20
  • 12 Days 1903.30
  • 100 Days 2146.50
  • 20 Days 1940.00
  • 200 Days 2003.80
1797.47
PIVOT
First Resistance 1814.93
Second Resistance 1841.37
Third Resistance 1858.83
First Support 1771.03
Second Support 1753.57
Third Support 1727.13
RSI 46.86
MACD -58.23
Commodity Channel Index (CCI) -146.05
ADX 11.98
Williams % R -80.32

Over 1 Month

down

-15.07

Over 3 Months

down

-25.94

Over 6 Months

down

-25.19

Over 1 Year

down

-8.43

Over 3 Years

down

-1.45

Over 5 Years

down

0.00

NGL FINE CHEM LIMITED Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

NGL FINE CHEM LIMITED Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Others
27.24
Promoter Holdings
72.73
FII
0.01
DII
0.0
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Rajesh Lawande Shareholding of Promoter and Promoter Group 1352366.0 21.89
Rahul Nachane Shareholding of Promoter and Promoter Group 1083450.0 17.54
Sunita Potdar Shareholding of Promoter and Promoter Group 826510.0 13.38
Ajita Nachane Shareholding of Promoter and Promoter Group 713449.0 11.55
Pci Ferrmone Chemicals(india) Pvt Ltd Shareholding of Promoter and Promoter Group 517871.0 8.38
Debashish Neogi Public Shareholding 68666.0 1.11
Pushpa Lawande Shareholding of Promoter and Promoter Group 0.0 0.0

NGL FINE CHEM LIMITED

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
2023-08-18 1.75 Final 2023-08-18 Equity shares 2022-06-22 1.75 Final 2022-06-23 Equity shares 2021-08-12 1.75 Final 2021-08-13 Equity shares 2020-08-06 1.75 Final 2020-08-07 Equity shares 2019-08-13 1.75 Final 2019-08-16 Equity shares 2007-08-08 0.5 Final 2007-08-10 Equity shares
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About NGL FINE CHEM LIMITED

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by NGL FINE CHEM LIMITED

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of NGL Fine Chem Ltd?

Answer Field

The share price of NGL Fine Chem Ltd for NSE is ₹ 1800 and for BSE is ₹ 1805.

What is the Market Cap of NGL Fine Chem Ltd?

Answer Field

The market cap of NGL Fine Chem Ltd for NSE is ₹ 11,12.04 Cr. and for BSE is ₹ 11,15.13 Cr. as of now.

What is the 52 Week High and Low of NGL Fine Chem Ltd?

Answer Field

The 52 Week High and Low of NGL Fine Chem Ltd for NSE is ₹ 2823.90 and ₹ 1702.35 and for BSE is ₹ 2822.50 and ₹ 1728.60.

How to Buy NGL Fine Chem Ltd share?

Answer Field

You can trade in NGL Fine Chem Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for NGL Fine Chem Ltd?

Answer Field

The 1 year returns on the stock has been -8.43%.

What is the Current Share Price of NGL Fine Chem Ltd?

Answer Field

NGL Fine Chem Ltd share price is for NSE ₹ 1800 & for BSE ₹ 1805 as on Nov 21 2024 03:29 PM.

What is the Market Cap of NGL Fine Chem Ltd Share?

Answer Field

The market cap of NGL Fine Chem Ltd for NSE ₹ 11,12.04 & for BSE ₹ 11,15.13 as on Nov 21 2024 03:29 PM.

What is the P/E Ratio of NGL Fine Chem Ltd Share?

Answer Field

As on Nov 21 2024 03:29 PM the price-to-earnings (PE) ratio for NGL Fine Chem Ltd share is 29.65.

What is the PB ratio of NGL Fine Chem Ltd Share?

Answer Field

As on Nov 21 2024 03:29 PM, the price-to-book (PB) ratio for NGL Fine Chem Ltd share is 451.95.

How to Buy NGL Fine Chem Ltd Share?

Answer Field

You can trade in NGL Fine Chem Ltd shares with Bajaj Broking by opening a demat account.

How to Buy NGL Fine Chem Ltd Share on Bajaj Broking App?

Answer Field

To buy NGL Fine Chem Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “NGL Fine Chem Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

8 Lacs + Users

icon-with-text

4.8+ App Rating

icon-with-text

4 Languages

icon-with-text

₹5000+ Cr MTF Book

icon-with-text
loader